Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multimodal Sleep Pathway in Hospitalized Orthopedic Trauma Patients
NCT07336277Phase 3Recruiting
- Sponsor
- Emory University
- Start
- Jun 2026
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zolpidem sublingual tablet, melatonin in sleep disorder, sponsored by Emory University. Started Jun 2026; status: recruiting.
02
Drugs
zolpidem sublingual tabletmelatonin
03
Conditions
sleep disorder
Beyond the preview
Go deeper on NCT07336277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07336277.